摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[9-((2R,3S,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-isobutyramide | 199601-35-9

中文名称
——
中文别名
——
英文名称
N-[9-((2R,3S,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-isobutyramide
英文别名
N2-Isobutyryl-9-(b-d-arabinofuranosyl)guanine;N-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
N-[9-((2R,3S,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-isobutyramide化学式
CAS
199601-35-9
化学式
C14H19N5O6
mdl
——
分子量
353.335
InChiKey
OXTYJSXVUGJSGM-LJUQJJLCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    158
  • 氢给体数:
    5
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SYNTHESIS OF 3'N NUCLEOSIDES THROUGH OXIME INTERMEDIATES AND RELATED COMPOUNDS<br/>[FR] SYNTHÈSE DE 3'N NUCLÉOSIDES AU MOYEN D'INTERMÉDIAIRES D'OXIME ET DE COMPOSÉS APPARENTÉS
    申请人:JANSSEN BIOPHARMA INC
    公开号:WO2021186328A1
    公开(公告)日:2021-09-23
    Provided herein are novel synthetic routes to amines through an oxime intermediate, e.g., 3'-N nucleosides and novel and intermediate compounds produced during these synthetic procedures.
    本文提供了一种通过肟中间体合成胺类化合物的新颖方法,例如3'-N核苷和在这些合成过程中产生的新颖和中间化合物。
  • METHODS FOR SYNTHESIZING NUCLEOSIDES, NUCLEOSIDE DERIVATIVES AND NON-NUCLEOSIDE DERIVATIVES
    申请人:RIBOZYME PHARMACEUTICALS, INC.
    公开号:EP1313752A2
    公开(公告)日:2003-05-28
  • COMPOSITION OF ANTIBODY CONSTRUCT-AGONIST CONJUGATES AND METHODS OF USE THEREOF
    申请人:Opi Vi- IP Holdco LLC
    公开号:EP3386536A2
    公开(公告)日:2018-10-17
  • COMPOSITIONS OF ANTIBODY CONSTRUCT-AGONIST CONJUGATES AND METHODS OF USE THEREOF
    申请人:OPI VI - IP HoldCo LLC
    公开号:US20170298139A1
    公开(公告)日:2017-10-19
    Various antibody construct compositions are disclosed. The compositions of antibody construct-immune stimulatory compound conjugates are also provided. Additionally provided are the methods of preparation and used of the antibody construct-immune stimulatory compound conjugates. This includes methods for treating disorders, such as cancer. A genus of STING agonist compounds and method of synthesis is also disclosed.
  • [EN] METHODS FOR SYNTHESIZING NUCLEOSIDES, NUCLEOSIDE DERIVATIVES AND NON-NUCLEOSIDE DERIVATIVES<br/>[FR] PROCEDE DE SYNTHESE DE NUCLEOSIDES, DE NUCLEOSIDES EN DERIVANT, ET DE LEURS DERIVES NON NUCLEOSIDES
    申请人:RIBOZYME PHARM INC
    公开号:WO2002018405A2
    公开(公告)日:2002-03-07
    The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2'-amino, 2'-N-phthaloyl, 2'-O-methyl, 2'-O-silyl, 2'-OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucleoside phosphoramidites, and non-nucleoside derivatives.
查看更多